Market Drivers The Global Chaple Disease Therapeutics Market is being propelled by several key drivers. One significant driver is the increasing prevalence of Chaple disease worldwide. Chaple disease, a chronic autoimmune disorder characterized by inflammation of the joints and surrounding tissues, affects millions of people globally. This rising prevalence has created a growing demand for...